Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 2nd December 2024
Solactive China Healthcare Disruption Index:
In the ordinary adjustment, the following composition will be implemented effective open 2nd December 2024:
HUTCHMED CHINA LTD | 0.4897 % |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 8.0 % |
SIHUAN PHARMACEUTICAL HLDGS GRP ORD | 0.1323 % |
GRAND PHARMACEUTICAL GROUP LTD | 0.3531 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.3929 % |
CSPC PHARMACEUTICAL GROUP LTD | 8.0 % |
SINO BIOPHARMACEUTICAL LTD ORD | 8.0 % |
SHANGHAI FUDAN-ZHANGJIANG BIO- | 1.2682 % |
LIVZON PHARMACEUTICAL GROUP INC | 5.6316 % |
GENSCRIPT BIOTECH CORP | 4.205 % |
YICHANG HEC CHANGJIANG PHA-H | 0.1328 % |
INNOVENT BIOLOGICS INC | 8.0 % |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 4.6347 % |
SIMCERE PHARMACEUTICAL GROUP | 0.3786 % |
LEPU BIOPHARMA CO LTD-H | 0.1118 % |
KEYMED BIOSCIENCES INC | 0.2329 % |
LUYE PHARMA GROUP LTD | 0.2126 % |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 8.0 % |
SHANGHAI MICROPORT MEDBOT GR | 1.4666 % |
WUXI BIOLOGICS CAYMAN INC | 8.0 % |
WUXI APPTEC CO LTD | 8.0 % |
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.5 % |
CHINA RESOURCES PHARMACEUTICAL | 5.7941 % |
HANSOH PHARMACEUTICAL GROUP CO | 8.0 % |
PHARMARON BEIJING CO LTD-H | 0.5 % |
AIM VACCINE CO LTD | 0.0728 % |
SKB BIO-B ORD H | 0.4492 % |
ZAI LAB LTD | 0.4532 % |
AKESO INC | 8.0 % |
ALPHAMAB ONCOLOGY | 0.0978 % |
REMEGEN CO LTD-H | 0.3366 % |
KANGJI MEDICAL HOLDINGS LTD | 0.1537 % |